In NSCLC and head and neck squamous cell carcinoma (HNSCC) cells, JUN overexpression coincides with acquired resistance to cetuximab and is accompanied by increased expression of AXL (101). This evidence concerns the gene AXL and non-small cell lung carcinoma.